Skip to main content
Erschienen in: Child's Nervous System 1/2005

01.01.2005 | Original Paper

Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children

verfasst von: Henry E. Aryan, Hal S. Meltzer, Min S. Park, Rebecca L. Bennett, Rahul Jandial, Michael L. Levy

Erschienen in: Child's Nervous System | Ausgabe 1/2005

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Infection is a major complication of cerebrospinal fluid (CSF) shunting procedures. Recently, rifampin-impregnated and clindamycin-impregnated silicone catheters have been developed in an attempt to prevent and/or reduce the incidence of shunt infections. In vitro and in vivo animal studies have shown their efficacy in reducing bacterial colonization of catheters. However, these shunts are yet to be evaluated in clinical trials and their safety and efficacy in preventing shunt infections is unknown.

Methods

Between April 2002 and April 2003, 31 children (age range 6 months to 17 years, mean 4.5 years) underwent implantation of an antibiotic-impregnated silicone catheter for CSF diversion. All surgeries were performed by a single neurosurgeon (HSM) at a single medical center. The Codman Hakim Bactiseal silicone catheter was used in all children. Thirty-two catheters were implanted in 31 children. All children have been followed since surgery (for an average of 19 months). For comparison, the previous 46 standard implanted shunts over a similar period of time were reviewed (average follow-up 31 months).

Results

Of the 32 implanted catheters, 11 involved placement of a new complete shunt system, 8 were distal revisions, and 13 were proximal/ventricular revisions. There were fewer early and late complications than in the standard shunt group (12.5 and 18.8% vs. 23.9 and 34.8%). There was no local reaction from implantation of the catheters. One child contaminated his distal catheter by disrupting his abdominal incision. None of the other patients have developed any evidence of shunt infection to date.

Conclusion

Rifampin-impregnated and clindamycin-impregnated silicone catheters appear to be safe and well tolerated in children. Preliminary results suggest a low incidence of shunt infection. Longer follow-up and a larger number of patients are needed to more accurately assess the efficacy of these catheters compared with traditional silicone catheters.
Literatur
1.
Zurück zum Zitat Abed WT, Alavijeh MS, Bayston R, Shorvon SD, Patsalos PN (1994) An evaluation of the epileptogenic properties of a rifampin/clindamycin-impregnated shunt catheter. Br J Neurosurg 8:725–730PubMed Abed WT, Alavijeh MS, Bayston R, Shorvon SD, Patsalos PN (1994) An evaluation of the epileptogenic properties of a rifampin/clindamycin-impregnated shunt catheter. Br J Neurosurg 8:725–730PubMed
2.
Zurück zum Zitat Alleyne CH Jr, Hassan M, Zabramski JM (2000) The efficacy and cost of prophylactic and periprocedural antibiotics in patients with external ventricular drains. Neurosurgery 47:1124–1127CrossRefPubMed Alleyne CH Jr, Hassan M, Zabramski JM (2000) The efficacy and cost of prophylactic and periprocedural antibiotics in patients with external ventricular drains. Neurosurgery 47:1124–1127CrossRefPubMed
3.
Zurück zum Zitat Ammirati M, Raimondi A (1987) Cerebrospinal fluid shunt infections in children: a study of the relationship between the etiology and the hydrocephalus, age at the time of shunt placement, and infection. Childs Nerv Syst 3:106–109CrossRefPubMed Ammirati M, Raimondi A (1987) Cerebrospinal fluid shunt infections in children: a study of the relationship between the etiology and the hydrocephalus, age at the time of shunt placement, and infection. Childs Nerv Syst 3:106–109CrossRefPubMed
4.
Zurück zum Zitat Bayston R, Lambert E (1997) Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. J Neurosurg 87:247–251PubMed Bayston R, Lambert E (1997) Duration of protective activity of cerebrospinal fluid shunt catheters impregnated with antimicrobial agents to prevent bacterial catheter-related infection. J Neurosurg 87:247–251PubMed
5.
Zurück zum Zitat Bayston R, Lari J (1974) A study of the sources of infection in colonized shunts. Dev Med Child Neurol Suppl 32:16–22 Bayston R, Lari J (1974) A study of the sources of infection in colonized shunts. Dev Med Child Neurol Suppl 32:16–22
6.
Zurück zum Zitat Bayston R, Grove N, Siegel J, Lawellin D, Barsham S (1989) Prevention of hydrocephalus shunt catheter colonization in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry 52:605–609PubMed Bayston R, Grove N, Siegel J, Lawellin D, Barsham S (1989) Prevention of hydrocephalus shunt catheter colonization in vitro by impregnation with antimicrobials. J Neurol Neurosurg Psychiatry 52:605–609PubMed
7.
Zurück zum Zitat Brown EM, de Louvois J, Bayston R (1994) Antimicrobial prophylaxis in neurosurgery and after head injury. Lancet 344:1547–1551CrossRefPubMed Brown EM, de Louvois J, Bayston R (1994) Antimicrobial prophylaxis in neurosurgery and after head injury. Lancet 344:1547–1551CrossRefPubMed
8.
Zurück zum Zitat Choi SH, McComb JG, Levy ML, Gonzalez-Gomez I, Bayston R (2003) Use of elemental iodine for shunt infection prophylaxis. Neurosurgery 52:908–913CrossRefPubMed Choi SH, McComb JG, Levy ML, Gonzalez-Gomez I, Bayston R (2003) Use of elemental iodine for shunt infection prophylaxis. Neurosurgery 52:908–913CrossRefPubMed
9.
Zurück zum Zitat Christiansen GD, Simpson WA, Bisno AL, Beachey EH (1982) Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immunol 37:318–325 Christiansen GD, Simpson WA, Bisno AL, Beachey EH (1982) Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immunol 37:318–325
10.
Zurück zum Zitat Diaz-Mitoma F, Harding GKM, Hoban DJ, Roberts RS, Low DE (1987) Clinical significance of a test for slime production in ventriculoperitoneal shunt infections caused by coagulase-negative staphylococci. J Infect Dis 156:555–560PubMed Diaz-Mitoma F, Harding GKM, Hoban DJ, Roberts RS, Low DE (1987) Clinical significance of a test for slime production in ventriculoperitoneal shunt infections caused by coagulase-negative staphylococci. J Infect Dis 156:555–560PubMed
11.
Zurück zum Zitat Drake JM, Kestle JRW, Milner R, Cinalli G, Boop F, Piatt J, Haines S, Schiff SJ, Cochrane DD, Steinbok P, MacNeil N et al (1998) Randomized trail of cerebrospinal fluid shunt valve design in pediatric hydrocephalus. Neurosurgery 43:294–305CrossRefPubMed Drake JM, Kestle JRW, Milner R, Cinalli G, Boop F, Piatt J, Haines S, Schiff SJ, Cochrane DD, Steinbok P, MacNeil N et al (1998) Randomized trail of cerebrospinal fluid shunt valve design in pediatric hydrocephalus. Neurosurgery 43:294–305CrossRefPubMed
12.
Zurück zum Zitat Forward KR, Fewer HD, Stiver HG (1983) Cerebrospinal fluid shunt infections. A review of 35 infections in 32 patients. J Neurosurg 59:389–394PubMed Forward KR, Fewer HD, Stiver HG (1983) Cerebrospinal fluid shunt infections. A review of 35 infections in 32 patients. J Neurosurg 59:389–394PubMed
13.
Zurück zum Zitat Frame PT, McLaurin RL (1984) Treatment of CSF shunt infection with intrashunt plus oral antibiotic therapy. J Neurosurg 60:354–360PubMed Frame PT, McLaurin RL (1984) Treatment of CSF shunt infection with intrashunt plus oral antibiotic therapy. J Neurosurg 60:354–360PubMed
14.
Zurück zum Zitat Gardner P, Leipzig T, Phillips P (1985) Infections of central nervous system shunts. Med Clin North Am 69:297–314PubMed Gardner P, Leipzig T, Phillips P (1985) Infections of central nervous system shunts. Med Clin North Am 69:297–314PubMed
15.
Zurück zum Zitat George R, Leibrock L, Epstein M (1979) Long-term analysis of cerebrospinal fluid shunt infections: a 25 year experience. J Neurosurg 51:804–811PubMed George R, Leibrock L, Epstein M (1979) Long-term analysis of cerebrospinal fluid shunt infections: a 25 year experience. J Neurosurg 51:804–811PubMed
16.
Zurück zum Zitat Gray ED, Peters G, Verstegen M, Regelmann WE (1984) Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response. Lancet 1:1365–1367 Gray ED, Peters G, Verstegen M, Regelmann WE (1984) Effect of extracellular slime substance from Staphylococcus epidermidis on the human cellular immune response. Lancet 1:1365–1367
17.
Zurück zum Zitat Guevara JA, Zuccaro G, Trevisan A, Denoya CD (1987) Bacterial adhesion to cerebrospinal shunts. J Neurosurg 67:438–445PubMed Guevara JA, Zuccaro G, Trevisan A, Denoya CD (1987) Bacterial adhesion to cerebrospinal shunts. J Neurosurg 67:438–445PubMed
18.
Zurück zum Zitat Hampl J, Schierholz J, Jansen B, Aschoff A (1995) In vitro and in vivo efficacy of a rifampin-loaded silicone catheter for the prevention of CSF shunt infections. Acta Neurochir (Wien) 133:147–152 Hampl J, Schierholz J, Jansen B, Aschoff A (1995) In vitro and in vivo efficacy of a rifampin-loaded silicone catheter for the prevention of CSF shunt infections. Acta Neurochir (Wien) 133:147–152
19.
Zurück zum Zitat James HE, Walsh JW, Wilson HD, Connor JD, Bean JR, Tibbs PA (1980) Prospective randomized study of therapy in cerebrospinal fluid shunt infection. Neurosurgery 7:459–463PubMed James HE, Walsh JW, Wilson HD, Connor JD, Bean JR, Tibbs PA (1980) Prospective randomized study of therapy in cerebrospinal fluid shunt infection. Neurosurgery 7:459–463PubMed
20.
Zurück zum Zitat Johnson GM, Regelmann WE, Gray ED (1987) Staphylococcal slime and host defenses: effects on polymorphonuclear granulocytes. Zentralbl Bakteriol Suppl 16:33–43 Johnson GM, Regelmann WE, Gray ED (1987) Staphylococcal slime and host defenses: effects on polymorphonuclear granulocytes. Zentralbl Bakteriol Suppl 16:33–43
21.
Zurück zum Zitat Keutcher TR, Mealey J (1979) Long-term results after ventriculoatrial and ventriculoperitoneal shunting for infantile hydrocephalus. J Neurosurg 50:179–186 Keutcher TR, Mealey J (1979) Long-term results after ventriculoatrial and ventriculoperitoneal shunting for infantile hydrocephalus. J Neurosurg 50:179–186
22.
Zurück zum Zitat Kockro RA, Hampl JA, Jansen B, Peters G, Scheihing M, Giacomelli R, Kunze S, Aschoff A (2000) Use of scanning electron microscopy to investigate the prophylactic efficacy of rifampin-impregnated CSF shunt catheters. J Med Microbiol 49:441–450PubMed Kockro RA, Hampl JA, Jansen B, Peters G, Scheihing M, Giacomelli R, Kunze S, Aschoff A (2000) Use of scanning electron microscopy to investigate the prophylactic efficacy of rifampin-impregnated CSF shunt catheters. J Med Microbiol 49:441–450PubMed
23.
Zurück zum Zitat Kohnen W, Schaper J, Klein O, Tieke B, Jansen B (1998) A silicone ventricular catheter coated with a combination of rifampin and trimethoprim for the prevention of catheter-related infections. Zentralbl Bakteriol 287:147–156PubMed Kohnen W, Schaper J, Klein O, Tieke B, Jansen B (1998) A silicone ventricular catheter coated with a combination of rifampin and trimethoprim for the prevention of catheter-related infections. Zentralbl Bakteriol 287:147–156PubMed
24.
Zurück zum Zitat Kontny U, Hofling B, Gutjahr P, Voth D, Schwarz M, Schmitt HJ (1993) CSF shunt infections in children. Infection 21:89–92PubMed Kontny U, Hofling B, Gutjahr P, Voth D, Schwarz M, Schmitt HJ (1993) CSF shunt infections in children. Infection 21:89–92PubMed
25.
Zurück zum Zitat Kulkarni AV, Rabin D, Lamberti-Pasculli M, Drake JM (2001) Repeat cerebrospinal fluid shunt infection in children. Pediatr Neurosurg 35:66–71CrossRefPubMed Kulkarni AV, Rabin D, Lamberti-Pasculli M, Drake JM (2001) Repeat cerebrospinal fluid shunt infection in children. Pediatr Neurosurg 35:66–71CrossRefPubMed
26.
Zurück zum Zitat Langley JM, LeBlanc JC, Drake J, Milner R (1993) Efficacy of antimicrobial prophylaxis in placement of cerebrospinal fluid shunts: meta-analysis. Clin Infect Dis 17:98–103PubMed Langley JM, LeBlanc JC, Drake J, Milner R (1993) Efficacy of antimicrobial prophylaxis in placement of cerebrospinal fluid shunts: meta-analysis. Clin Infect Dis 17:98–103PubMed
27.
Zurück zum Zitat McLaurin RL (1975) Treatment of infected ventricular shunts. Childs Brain 1:306–310PubMed McLaurin RL (1975) Treatment of infected ventricular shunts. Childs Brain 1:306–310PubMed
28.
Zurück zum Zitat Odio C, McCracken GH Jr, Nelson JD (1984) CSF shunt infections in pediatrics: a seven-year experience. Am J Dis Child 138:1103–1108PubMed Odio C, McCracken GH Jr, Nelson JD (1984) CSF shunt infections in pediatrics: a seven-year experience. Am J Dis Child 138:1103–1108PubMed
29.
Zurück zum Zitat Peters G, Locci R, Pulverer G (1982) Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis 146:479–482PubMed Peters G, Locci R, Pulverer G (1982) Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis 146:479–482PubMed
30.
Zurück zum Zitat Pople IK, Bayston R, Hayward RD (1992) Infection of cerebrospinal fluid shunts in infants: a study of etiological factors. J Neurosurg 77:29–36PubMed Pople IK, Bayston R, Hayward RD (1992) Infection of cerebrospinal fluid shunts in infants: a study of etiological factors. J Neurosurg 77:29–36PubMed
31.
Zurück zum Zitat Ronan A, Hogg GG, Klug GL (1995) Cerebrospinal fluid shunt infections in children. Pediatr Infect Dis J 14:782–786PubMed Ronan A, Hogg GG, Klug GL (1995) Cerebrospinal fluid shunt infections in children. Pediatr Infect Dis J 14:782–786PubMed
32.
Zurück zum Zitat Schierholz JM, Pulverer G (1997) Development of a new CSF-shunt with sustained release of an antimicrobial broad-spectrum combination. Zentralbl Bakteriol 286:107–123PubMed Schierholz JM, Pulverer G (1997) Development of a new CSF-shunt with sustained release of an antimicrobial broad-spectrum combination. Zentralbl Bakteriol 286:107–123PubMed
33.
Zurück zum Zitat Schierholz J, Jansen B, Jaenicke L, Pulverer G (1994) In vitro efficacy of an antibiotic releasing silicone ventricle catheter to prevent shunt infection. Biomaterials 15:996–1000CrossRefPubMed Schierholz J, Jansen B, Jaenicke L, Pulverer G (1994) In vitro efficacy of an antibiotic releasing silicone ventricle catheter to prevent shunt infection. Biomaterials 15:996–1000CrossRefPubMed
34.
Zurück zum Zitat Schoenbaum SC, Gardner P, Shillito J (1975) Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J Infect Dis 131:543–552PubMed Schoenbaum SC, Gardner P, Shillito J (1975) Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J Infect Dis 131:543–552PubMed
35.
Zurück zum Zitat Shapiro S, Boaz J, Kleiman M, Kalsbeck J, Mealey J (1988) Origin of organisms infecting ventricular shunts. Neurosurgery 22:868–872PubMed Shapiro S, Boaz J, Kleiman M, Kalsbeck J, Mealey J (1988) Origin of organisms infecting ventricular shunts. Neurosurgery 22:868–872PubMed
36.
Zurück zum Zitat Tomaszek DE, Powers SK (1985) Treatment of cerebrospinal fluid and syringosubarachnoid shunt infection with systemic and intrathecal antibiotics. Neurosurgery 17:327–328PubMed Tomaszek DE, Powers SK (1985) Treatment of cerebrospinal fluid and syringosubarachnoid shunt infection with systemic and intrathecal antibiotics. Neurosurgery 17:327–328PubMed
37.
Zurück zum Zitat Whitehead WE, Kestle JRW (2001) The treatment of cerebrospinal fluid shunt infections. Pediatr Neurosurg 35:205–210CrossRefPubMed Whitehead WE, Kestle JRW (2001) The treatment of cerebrospinal fluid shunt infections. Pediatr Neurosurg 35:205–210CrossRefPubMed
38.
Zurück zum Zitat Yogev R (1985) Cerebrospinal shunt infections: a personal view. Pediatr Infect Dis 4:113–118PubMed Yogev R (1985) Cerebrospinal shunt infections: a personal view. Pediatr Infect Dis 4:113–118PubMed
Metadaten
Titel
Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children
verfasst von
Henry E. Aryan
Hal S. Meltzer
Min S. Park
Rebecca L. Bennett
Rahul Jandial
Michael L. Levy
Publikationsdatum
01.01.2005
Erschienen in
Child's Nervous System / Ausgabe 1/2005
Print ISSN: 0256-7040
Elektronische ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-004-1052-x

Weitere Artikel der Ausgabe 1/2005

Child's Nervous System 1/2005 Zur Ausgabe

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Wie sieht der OP der Zukunft aus?

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Recycling im OP – möglich, aber teuer

02.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.